Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of minority populations of HIV type-1 with K103N and M184V drug resistance mutations among children in Argentina.

Antiviral therapy - 1 Jan 2009

Vignoles Moira, Barboni Graciela, Agosti María R, Quarleri Jorge, García Mariel K, Ayala Silvia González, Salomón Horacio

Abstract excerpt

BACKGROUND: The aim of this study was to describe the frequency of minority populations of viruses carrying mutations K103N and M184V in drug-naive HIV type-1 (HIV-1)-infected children, and to further evaluate their effect on the selection of drug-resistant viruses within highly active antiretrov...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Antiretroviral Therapy, Highly Active
Share to Argentina

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Administration Schedule

Share to Genes, pol

Share to Lamivudine

Share to Nevirapine

Share to Reverse Transcriptase Inhibitors

Source

Identifiers

PMID: 20032547
DOI: 10.3851/IMP1461

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20032547-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of minority populations of HIV type-1 with K103N and M184V drug resistance mutations among children in Argentina.PMID 20032547Read ↗

Prevalence of key resistance mutations K65R, K103N, and M184V as minority HIV-1 variants in chronically HIV-1 infected, treatment-naïve patients.Semantic proximity Read ↗

Minority HIV-1 drug-resistant mutations and prevention of mother-to-child transmission: perspectives for resource-limited countries.Semantic proximity Read ↗

Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy.Semantic proximity Read ↗

Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacy.Semantic proximity Read ↗

Clinical implications of HIV-1 minority variants.Semantic proximity Read ↗

High frequency of integrase Q148R minority variants in HIV-infected patients naive of integrase inhibitors.Semantic proximity Read ↗

Minority quasispecies of drug-resistant HIV-1 that lead to early therapy failure in treatment-naive and -adherent patients.Semantic proximity Read ↗

Efficient Suppression of Minority Drug‐Resistant HIV Type 1 (HIV‐1) Variants Present at Primary HIV‐1 Infection by Ritonavir‐Boosted Protease Inhibitor–Containing Antiretroviral TherapySemantic proximity Read ↗

Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen.Semantic proximity Read ↗

HIV type-1 drug resistance in treatment-naive patients monitored using minority species assays: a systematic review and meta-analysis.Semantic proximity Read ↗

Overview of genotypic and clinical profiles of human immunodeficiency virus type 1-infected children in Rio de Janeiro, Brazil.Semantic proximity Read ↗

Reappearance of minority K103N HIV-1 variants after interruption of ART initiated during primary HIV-1 infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.